Taro Pharmaceutical Industries Ltd
NYSE:TARO

Watchlist Manager
Taro Pharmaceutical Industries Ltd Logo
Taro Pharmaceutical Industries Ltd
NYSE:TARO
Watchlist
Price: 42.3 USD 0.24%
Updated: May 20, 2024

Taro Pharmaceutical Industries Ltd
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Taro Pharmaceutical Industries Ltd
Depreciation & Amortization Peer Comparison

Comparables:
TEVA
I
INCR
MDWD
R
REKA
C
CSURE

Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Taro Pharmaceutical Industries Ltd
NYSE:TARO
Depreciation & Amortization
$33.7m
CAGR 3-Years
14%
CAGR 5-Years
13%
CAGR 10-Years
7%
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Depreciation & Amortization
$1.1B
CAGR 3-Years
-10%
CAGR 5-Years
-9%
CAGR 10-Years
-4%
I
InterCure Ltd
TASE:INCR
Depreciation & Amortization
₪13.2m
CAGR 3-Years
59%
CAGR 5-Years
321%
CAGR 10-Years
56%
Mediwound Ltd
NASDAQ:MDWD
Depreciation & Amortization
$1.3m
CAGR 3-Years
6%
CAGR 5-Years
18%
CAGR 10-Years
14%
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Depreciation & Amortization
₪29.9m
CAGR 3-Years
15%
CAGR 5-Years
23%
CAGR 10-Years
16%
C
Cannassure Therapeutics Ltd
TASE:CSURE
Depreciation & Amortization
₪3.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Taro Pharmaceutical Industries Ltd's Depreciation & Amortization?
Depreciation & Amortization
33.7m USD

Based on the financial report for Dec 31, 2023, Taro Pharmaceutical Industries Ltd's Depreciation & Amortization amounts to 33.7m USD.

What is Taro Pharmaceutical Industries Ltd's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
7%

Over the last year, the Depreciation & Amortization growth was 20%. The average annual Depreciation & Amortization growth rates for Taro Pharmaceutical Industries Ltd have been 14% over the past three years , 13% over the past five years , and 7% over the past ten years .